Heavy cannabis use could pose this threat to the brain
As cannabis is legalized in more states across the country, new research points to the negative side effects of partaking too much.
Researchers from the University of Colorado Anschutz Medical Campus looked into the impact of recent and lifetime cannabis use on brain function during cognitive tasks.
The study, published in the journal JAMA Open Network, is the "largest of its kind," according to the university, using brain imaging technology to examine the effects of cannabis use on 1,000 young adults from 22 to 36 years old.
Daily Marijuana Smokers Face Higher Risk Of Heart Attack, Stroke, Says American Heart Association Study
The cannabis users were tested on their "working memory," which is the ability to retain and use information to perform tasks, like solving a math problem.
Neural response was measured through seven cognitive tests – probing working memory, reward, emotion, language and motor skills – such as "tapping a finger to map brain control, relational assessment and theory of mind."
Read On The Fox News App
The results showed that 63% of heavy lifetime cannabis users demonstrated reduced brain activity while completing a working memory task.
Meanwhile, 68% of recent cannabis users exhibited a similar impact.
Older Americans Turn To Marijuana For Better Sleep And Pain Relief: Here's What To Know
The researchers concluded that cannabis had a "statistically significant effect" on brain function during working memory tasks, but was less significant in other tasks.
There was reduced brain activity in areas involved in important cognitive functions like decision-making, memory, attention and emotional processing.
Lead study author Joshua Gowin, PhD, assistant professor of radiology at the University of Colorado School of Medicine, stressed the importance of studying the effects of cannabis on health as it continues to "grow globally."
"By doing so, we can provide a well-rounded understanding of both the benefits and risks of cannabis use, empowering people to make informed decisions and fully comprehend the potential consequences," he said in a press release.
Marijuana Use Linked To Increased Asthma Risk In Youth, Study Says: 'Worrisome' Health Implications
Refraining from cannabis use before a cognitive task could help improve performance, according to Gowin and his team.
"People need to be aware of their relationship with cannabis, since abstaining cold turkey could disrupt their cognition as well," Gowin said. "For example, heavy users may need to be more cautious."
"There are a lot of questions … regarding how cannabis impacts the brain," he went on.
"Large, long-term studies are needed to understand whether cannabis use directly changes brain function, how long these effects last and the impact on different age groups."
Click Here To Sign Up For Our Health Newsletter
Neurosurgeon Dr. Paul Saphier, MD, pointed out that the overall study sample size is large, but that only about 8% of participants were reported as "heavy" users.
"While the study appears to be designed well … I'd like to see a larger sample size of heavy users compared to either moderate or non-users to draw any definitive data," the doctor, who was not involved in the study, shared with Fox News Digital.
For more Health articles, visit www.foxnews.com/health
Saphier, founder of Coaxial Neurosurgical Specialists in New Jersey, noted that he is "not surprised" by the study findings.
"Heavy use of cannabis over one's lifetime may ultimately lead to decreased cognitive/memory tasks," he confirmed.
"This also supports a relatively common and well-articulated lifestyle mantra of 'everything in moderation,' with the obvious exceptions of in-arguably deleterious activities/lifestyle choices."
The neurosurgeon added that he looks forward to a "more well-rounded and higher enrollment study of heavy and moderate users, so I can offer more definitive data to my own patients."Original article source: Heavy cannabis use could pose this threat to the brain
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Long-lasting HIV prevention shot heads toward approval
June 6 (UPI) -- A new vaccine to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month. If approved, the shot -- lenacapavir -- would be given twice a year and could be a big step forward in the fight against HIV. Drugmaker Gilead Sciences tested the shot in a study of women and girls. None of the participants who received the injections got HIV. That early success helped boost Gilead's stock by 73% over the past year, The Wall Street Journal reported. "We know it's challenging to take a daily pill for prevention, and we see an incredible opportunity here," said Johanna Mercier, Gilead's chief commercial officer Right now, more than 400,000 people in the United States use pills to prevent HIV, The Wall Street Journal added. These medications are referred to as PrEP, short for pre-exposure prophylaxis. Gilead expects the number of users to top 1 million by the next decade. Many people already say they'd prefer a shot over daily pills. In one survey of more than 500 PrEP users, 95% said they would switch to a long-acting injection. Sales of other long-acting options, like the shot Apretude from GSK, have risen sharply - up 63% in the past year. Even with strong results, Gilead faces several hurdles. One is reaching the people who need PrEP the most. Black Americans represent 39% of new HIV cases but only 14% of current PrEP users. Many people still face stigma or lack insurance coverage, which can limit access. Gilead says reaching underserved groups is a top goal. Most current PrEP users have commercial insurance, but Medicaid will be key for expanding access to lower-income communities. Another concern: Some experts worry the new shot may simply replace current Gilead products, like the daily pill Descovy, which now holds about 40% to 45% of the market. But Gilead says the shot should help expand the overall number of people using PrEP in both the U.S. and abroad. "We're thinking globally about the public health impact we can have," Mercier said. The company is working with governments and health groups in the United Kingdom and low-income countries to raise awareness and make these products more available. More information The National Institutes of Health has more on Pre-Exposure Prophylaxis (PrEP). Copyright © 2025 HealthDay. All rights reserved.
Yahoo
an hour ago
- Yahoo
Nearly 100 House Democrats urge RFK Jr. to restore millions in family planning grants
Nearly 100 House Democrats are calling on Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to restore tens of millions of dollars in federal family planning grants to more than a dozen organizations that have been frozen for more than two months. In a letter to Kennedy sent Friday and seen first by The Hill, 95 lawmakers said the organizations that had their Title X funding frozen on March 31 — including nine Planned Parenthood clinics — are still in the dark about the status of their grants. At the time, the clinics said they received letters from the administration saying the grants were being 'temporarily withheld' due to possible civil right violations and President Trump's executive orders prohibiting the promotion of diversity, equity and inclusion (DEI) and 'taxpayer subsidization of open borders.' More than two months later, the lawmakers said the grantees 'remain without funding and have received no communication from the administration regarding the status of the investigations, the expected timeline, or the future of their funding.' HHS declined to comment, citing ongoing litigation. The agency is being sued over the freeze by the National Family Planning and Reproductive Health Association (NFPRHA) and the American Civil Liberties Union (ACLU). 'Congress has already appropriated these funds, and the administration has a responsibility to distribute them without undue delay or obstruction, ensuring that critical care is not disrupted for millions of people who rely on Title X services,' the group of lawmakers wrote. The letter was led by Reps. Josh Gottheimer (D-N.J.), Judy Chu (D-Calif.), Lizzie Fletcher (D-Texas) and Sharice Davids (D-Kan.) and signed by 91 other Democrats. Title X is the country's only federal program dedicated to providing affordable birth control and other sexual and reproductive health care to low-income Americans and has done so since the 1970s. The lawmakers timed the letter to coincide with the 60th anniversary of the U.S. Supreme Court's ruling in Griswold v. Connecticut, which established a constitutional right to privacy regarding contraception and reproductive decisions. 'However, due to the actions of this administration, reproductive freedom is under threat,' the lawmakers wrote. The first Trump administration prohibited providers from receiving Title X funding if they mentioned abortion or referred patients for abortions. It also required clinics to construct separate facilities for the procedure and other services. More than a dozen grantees, including all Planned Parenthood affiliates nationwide, left the program in protest because of the rule. The Biden administration reversed Trump's Title X rule in 2021. Updated at 3:26 p.m. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Republicans are also sweating Medicaid cuts in Big Beautiful Bill, poll finds
More than four in 10 Republicans are worried about the Medicaid cuts being contemplated as a part of President Donald Trump's domestic policy mega-bill, a reminder that key parts of President Donald Trump's base also stand to be adversely impacted by the sprawling legislation. One-third of respondents to the new KFF poll identify as MAGA Republicans, reflecting the overall enrollment in the joint state/federal health care program. Among enrollees, more than a quarter are Republican, including 1 in 5 who identify as MAGA Republicans, according to the pollWhil. Republicans who control the U.S. Senate now have the bill, which passed the U.S. House by a single vote late last month. The upper chamber is contemplating its own changes to the legislation, which would blow up the deficit and impose sweeping social service cuts as it seeks to make Trump's first-term tax cuts permanent. The poll found that a large majority of rural Americans and those with lower household incomes, another key part of Trump's base, are worried that Medicaid reductions would lead to more children and adults losing coverage. They said they also feared it would harm health care providers in their communities and make it more difficult for them and their families to access care, according to the poll. Those findings broke down along partisan lines. Nonetheless, half of rural Republicans said they were worried about people becoming uninsured, according to the poll. Rural health care providers, who often rely on Medicaid funding, may be "especially vulnerable to the decreased federal spending included in the reconciliation bill," according to KFF pollsters. Public views on how the Republican White House's policies will impact the nation's health care system are largely partisan. But overall, most of the public says the administration's policies will weaken Medicaid and Medicare, including most Democrats and independents. Republicans said they expect those policies to strengthen or have no impact on these programs. Read More: A 'historic battle': Mass pols protest Medicaid cuts in 'Big Beautiful Bill' | John L. Micek Among Republican Medicaid enrollees, however, 'views are mixed with similar shares saying the policies will strengthen, weaken, or have no impact on the program they rely on,' according to the poll. In Massachusetts, Democratic Gov. Maura Healey and her allies in the state Legislature have predicted grim consequences for MassHealth, as Medicaid is known in the Bay State. As it's currently written, the bill that passed the U.S. House by a single vote last week would reduce Medicaid spending by nearly $700 billion over a decade, according to an analysis by the Congressional Budget Office. That would cost the state's health care system $1.75 billion, affecting 250,000 people statewide, MassLive previously reported. This is my classroom. ICE isn't welcome here. What a monk, a librarian and a dentist have to do with Harvard's fight with Trump Harvard relinquishes possession of slave photos after years-long dispute Trump says Musk has 'lost his mind' as he disses peace offering Judge blocks Trump admin from banning Harvard international students from entering US Read the original article on MassLive.
